<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of Experimental and Clinical Surgery</journal-id><journal-title-group><journal-title xml:lang="en">Journal of Experimental and Clinical Surgery</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник экспериментальной и клинической хирургии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2070-478X</issn><issn publication-format="electronic">2409-143X</issn><publisher><publisher-name xml:lang="en">Voronezh State Medical University named after N.N. Burdenko</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1592</article-id><article-id pub-id-type="doi">10.18499/2070-478X-2022-15-1-13-15</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>Памяти В.И.Булынина</subject></subj-group><subj-group subj-group-type="article-type"><subject>Unknown</subject></subj-group></article-categories><title-group><article-title xml:lang="en">ROLE OF INTRA-ARTERIAL CHEMOTHERAPY IN THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER (CLINICAL CASE)</article-title><trans-title-group xml:lang="ru"><trans-title>МЕСТО ВНУТРИАРТЕРИАЛЬНОЙ ХИМИОТЕРАПИИ В ЛЕЧЕНИИ ТРИЖДЫ НЕГАТИВНОГО РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ (КЛИНИЧЕСКИЙ СЛУЧАЙ)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Berdnikova</surname><given-names>Kira Olegovna</given-names></name><name xml:lang="ru"><surname>Бердникова</surname><given-names>Кира Олеговна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>врач-ординатор кафедры онкологии</p></bio><email>berdnikova.kira@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Moshurov</surname><given-names>Ivan Petrovich</given-names></name><name xml:lang="ru"><surname>Мошуров</surname><given-names>Иван Петрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>доктор медицинских наук, профессор, профессор кафедры онкологии ФГБОУ ВО «Воронежский Государственный Медицинский Университет им. Н.Н. Бурденко»</p></bio><email>ipmoshurov@vrngmu.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6893-4657</contrib-id><contrib-id contrib-id-type="spin">4129-1488</contrib-id><name-alternatives><name xml:lang="en"><surname>Ustinova</surname><given-names>Ustinova</given-names></name><name xml:lang="ru"><surname>Устинова</surname><given-names>Елена Юрьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Doctor of Medical Sciences, Professor, Department of Oncology</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, профессор, кафедра онкологии</p></bio><email>ustinova48@list.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Olshansky</surname><given-names>Mikhail Sergeevich</given-names></name><name xml:lang="ru"><surname>Ольшанский</surname><given-names>Михаил Сергеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>доктор медицинских наук, доцент, профессор кафедры онкологии ФГБОУ ВО «Воронежский Государственный Медицинский Университет им. Н.Н. Бурденко»</p></bio><email>msolshansky2010@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lobova</surname><given-names>Olesya Alexandrovna</given-names></name><name xml:lang="ru"><surname>Лобова</surname><given-names>Олеся Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>врач отделения рентгенохирургических методов диагностики и лечения БУЗ ВО ВОКОД</p></bio><email>mail@vokod.zdrav36.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Воронежский Государственный Медицинский Университет им. Н.Н. Бурденко</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Voronezh State Medical University named after V.I. N.N. Burdenko</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО "Воронежский государственный университет им. Н.Н. Бурденко"</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">БУЗ ВО ВОКОД</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-10-17" publication-format="electronic"><day>17</day><month>10</month><year>2022</year></pub-date><volume>15</volume><issue-title xml:lang="ru">Памяти В.И.Булынина</issue-title><fpage>13</fpage><lpage>15</lpage><history><date date-type="received" iso-8601-date="2022-04-28"><day>28</day><month>04</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-08-16"><day>16</day><month>08</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Voronezh N.N. Burdenko State Medical University</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, ФГБОУ ВО ВГМУ им. Н.Н. Бурденко Минздрава России</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Voronezh N.N. Burdenko State Medical University</copyright-holder><copyright-holder xml:lang="ru">ФГБОУ ВО ВГМУ им. Н.Н. Бурденко Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://vestnik-surgery.com/journal/about/editorialPolicies</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnik-surgery.com/journal/article/view/1592">https://vestnik-surgery.com/journal/article/view/1592</self-uri><abstract xml:lang="en"><p>Various types of treatment for triple-negative breast cancer are considered. On the example of a clinical case, the role of regional chemotherapy in the treatment of this pathology is reflected. The effectiveness of combined systemic and regional chemotherapy in the treatment of early stages of triple-negative breast cancer was evaluated.</p></abstract><trans-abstract xml:lang="ru"><p>Рассмотрены различные виды лечения трижды негативного рака молочной железы. На примере клинического случая отражена роль регионарной химиотерапии в лечении данной патологии. Оценена эффективность сочетанной системной и регионарной химиотерапии в лечении ранних стадий трижды негативного рака молочной железы. </p></trans-abstract><kwd-group xml:lang="en"><kwd>breast cancer</kwd><kwd>triple negative breast cancer</kwd><kwd>intraarterial chemotherapy</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак молочной железы</kwd><kwd>трижды негативный рак молочной железы</kwd><kwd>внутриартериальная химиотерапия</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Poddubnaya IV, Karseladze DA. Clinical characteristics of triple negative breast cancer. Journal of N.N. Blokhin RCRC. 2010; 21(1(79):71–76.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Molecular portraits of human breast tumours / Perou C. M., Sørlie T., Eisen M. B., van de Rijn M., Jeffrey S.S., Rees C. A., Pollack J. R., Ross D. T., Johnsen H., Akslen L. A., Fluge O., Pergamenschikov A., Williams C., Zhu S. X., Lønning P. E., Børresen-Dale A. L., Brown P. O., Botstein D. // Nature. — 2000. — Vol. 406, N 6797. — P. 747—752.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Pattern of metastatic spread in triple-negative breast cancer / Dent R., Hanna W. M., Trudeau M., Rawlinson E., Sun P., Narod S. A. // Breast Cancer Res. Treat. — 2008. — Vol. 115, N 2. — P. 423—428.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Nishimura R., Arima N. Is triple negative a prognostic factor in breast cancer? // Breast Cancer. — 2008. — Vol. 15, N 4. — P. 303—308.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype / Cheang M. C., Voduc D., Bajdik C., Leung S., McKinney S., Chia S. K., Perou C. M., Nielsen T. O. // Clin. Cancer Res. — 2008. — Vol. 14, N 5. — P. 1368—1376.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Semiglazov VF, Semiglazov VV. Breast cancer treatment. Clinical and biological study. Moscow: SIMK, 2017.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Kovalenko E. I. Adjuvant therapy of triple negative breast cancer // Video materials of the Big Conference RUSSCO "Breast Cancer", Moscow, January 22-24, 2014 — http://www.rosoncoweb.ru /events/2014/01/22/ archive.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Zhukova L. G. Modern possibilities of therapy of metastatic breast cancer with triple negative phenotype // Materials of the Big RUSSCO Conference Breast Cancer, Moscow, January 22-24 2014— Moscow, 2014.— pp. 235-241.</mixed-citation></ref></ref-list></back></article>
